Application of in silico methods in clinical research and development of drugs and their formulation: A scoping review
Open Access
- 1 January 2022
- journal article
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
- Vol. 13 (4) , 001-010
Abstract
The drug regularization process involves many steps that are complex and time-consuming. The demand for new drugs has prompted researchers and regulatory authorities to search for predictive methods that can streamline the development process. Current studies point to innovative computational techniques in a drug’s study phases. This study aims to carry out a scoping review of research involving the application of computational methods and in silico studies in the clinical research and development of new drugs. A scoping review was conducted according to the eferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Online databases from 2001 to 2021 in English were used and the trial registration was 10.17605/OSF.IO/USXCM. The development of protocols and the application of a computational method for researching new drugs and their formulation, published in a peer-reviewed journal, were included. The data extraction and analysis were performed by two independent reviewers. In this study, 312 articles were retrieved, of which 6 were duplicates. After the title was read, only 101 remained for analysis. After the abstracts were read, 34 papers were considered for the scoping review. The use of in silico methodologies has been expanding in terms of research into the development of new drugs and the improvement of existing products.Keywords
This publication has 25 references indexed in Scilit:
- Evaluating the Impact of Physiological Properties of the Gastrointestinal Tract On Drug In Vivo Performance Using Physiologically Based Biopharmaceutics Modeling and Virtual Clinical TrialsJournal of Pharmaceutical Sciences, 2021
- Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed statesEuropean Journal of Pharmaceutical Sciences, 2019
- In silico clinical trials: concepts and early adoptionsBriefings in Bioinformatics, 2018
- Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design mattersEpilepsy Research, 2017
- Physiologically based pharmacokinetics model predicts the lack of inhibition by repaglinide on the metabolism of pioglitazoneBiopharmaceutics & Drug Disposition, 2015
- Clinical trial simulation to evaluate population pharmacokinetics and food effect: Capturing abiraterone and nilotinib exposuresThe Journal of Clinical Pharmacology, 2014
- Pharmacogenomics and Translational Simulations to Bridge Indications for an Anti-Interferon-α Receptor AntibodyClinical Pharmacology & Therapeutics, 2013
- Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humansEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modelingEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Comparison of two types of population pharmacokinetic model structures of paclitaxelEuropean Journal of Pharmaceutical Sciences, 2008